Pazopanib in Previously Treated Patients With Metastatic Renal Cell Carcinoma

NCT00731211 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

57

Enrollment

OTHER

Sponsor class

Conditions

Renal Cell Carcinoma

Interventions

DRUG: Pazopanib

Sponsor

SCRI Development Innovations, LLC

Collaborators

[object Object]